GOLPH3, a Good Prognostic Indicator in Early-stage NSCLC Related to Tumor Angiogenesis

Lentivirus Mediated GOLPH3 shRNA Inhibits Growth and Metastasis of Esophageal Squamous Cancer

(2014) Qiang Wang et al.   Asian Pacific Journal of Cancer Prevention

Overexpression of GOLPH3 Promotes Proliferation and Tumorigenicity in Breast Cancer via Suppression of the FOXO1 Transcription Factor

(2012) Z. Zeng et al.   CLINICAL CANCER RESEARCH

Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer

(2012) Xing Hua et al.   Diagnostic Pathology

Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis

(2012) Jinxu Zhou et al.   JOURNAL OF NEURO-ONCOLOGY

GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer

(2012) Huan Li et al.   Journal of Translational Medicine

High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis

(2012) Jian-Hua Wang et al.   PLoS One

Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer

(2012) Ben-Shun Hu et al.   TUMOR BIOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Circulating MicroRNAs: Possible Prediction Biomarkers for Personalized Therapy of Non–Small-Cell Lung Carcinoma

(2011) Wen Gao et al.   Clinical Lung Cancer

Pathology of Lung Cancer

(2011) William D. Travis   CLINICS IN CHEST MEDICINE

GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer

(2009) Kenneth L. Scott et al.   NATURE